Omega Healthcare Investors (OHI) fundamentals: P/E, valuation, undervalued?
Omega Healthcare Investors · Real Estate · ref. ETF XLRE · price $46.29
In short — Omega Healthcare Investors trades at 16.5× earnings (P/E), 22.6× forward, with a net margin of 68.1 % and revenue growth of +11 %. Read: Cheap for the growth (P/E 23 for ~161% growth (PEG 0.1)).
Is Omega Healthcare Investors stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$46.29+9.7% over range
Aug 28, 25low $39.41 · high $51.72Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 9 analysts
Valuation : Cheap for the growth — P/E 23 for ~161% growth (PEG 0.1)
Valuation
16.5
P/E (price/earnings)
22.6
Forward P/E
0.10
PEG
2.6
Price/book (P/B)
$14.8B
Market cap
2.81
EPS
Profitability & growth
68.1 %
Net margin
+11 %
Revenue growth
+161 %
Earnings growth
$4.0B
Total debt
Omega Healthcare Investors income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $734M | $427M | 58.1 % |
| 2023 | $810M | $242M | 29.9 % |
| 2024 | $872M | $406M | 46.6 % |
| 2025 | $986M | $590M | 59.9 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Omega Healthcare Investors's P/E and is the stock undervalued? What's a good P/E?
Omega Healthcare Investors's P/E is 16.5 (forward 22.6). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Omega Healthcare Investors profitable?
Omega Healthcare Investors has a net margin of 68.1 % (EPS 2.81). The company is profitable.
Is OHI stock expensive?
Our read: "Cheap for the growth" — P/E 23 for ~161% growth (PEG 0.1). Cross-check with growth and sector.
💬 A question about Omega Healthcare Investors? The JPI assistant answers using our backtest data.
Keep exploring Omega Healthcare Investors